BPH Energy wins drug patent

North Perth-based BPH Energy, which has links to several Western Australian medical research organisations, has announced its drug discovery spin-out Molecular Discovery Systems has been granted a patent for a gene with tumour-suppressing potential.

MDS has exclusive rights to the HLS5 gene which ASX-listed BPH said has been given a high priority for research by organisations including the Cancer Council of WA, the Medical Research Foundation of Royal Perth Hospital and the Scott Kirkbride Melanoma Research Centre.

MDS is working with the WA Institute for Medical Research to further research HLS5.